MX2009007045A - Ciclosporina no inmunosupresora para el tratamiento de distrofia muscular congenita de ullrich. - Google Patents
Ciclosporina no inmunosupresora para el tratamiento de distrofia muscular congenita de ullrich.Info
- Publication number
- MX2009007045A MX2009007045A MX2009007045A MX2009007045A MX2009007045A MX 2009007045 A MX2009007045 A MX 2009007045A MX 2009007045 A MX2009007045 A MX 2009007045A MX 2009007045 A MX2009007045 A MX 2009007045A MX 2009007045 A MX2009007045 A MX 2009007045A
- Authority
- MX
- Mexico
- Prior art keywords
- muscular dystrophy
- treatment
- congenital muscular
- ullrich congenital
- immunosuppressive cyclosporin
- Prior art date
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title abstract 2
- 201000006814 Ullrich congenital muscular dystrophy Diseases 0.000 title abstract 2
- 229930105110 Cyclosporin A Natural products 0.000 title 1
- 108010036949 Cyclosporine Proteins 0.000 title 1
- 229960001265 ciclosporin Drugs 0.000 title 1
- 229930182912 cyclosporin Natural products 0.000 title 1
- 208000006304 Bethlem myopathy Diseases 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 230000004065 mitochondrial dysfunction Effects 0.000 abstract 1
- 210000000663 muscle cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87841407P | 2007-01-04 | 2007-01-04 | |
| PCT/IB2008/000003 WO2008084368A2 (en) | 2007-01-04 | 2008-01-03 | Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009007045A true MX2009007045A (es) | 2009-10-07 |
Family
ID=39514754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009007045A MX2009007045A (es) | 2007-01-04 | 2008-01-03 | Ciclosporina no inmunosupresora para el tratamiento de distrofia muscular congenita de ullrich. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8450281B2 (enExample) |
| EP (1) | EP2124992A2 (enExample) |
| JP (1) | JP5801534B2 (enExample) |
| CN (2) | CN105056207A (enExample) |
| AU (1) | AU2008204344B2 (enExample) |
| BR (1) | BRPI0806265A2 (enExample) |
| CA (1) | CA2674296C (enExample) |
| HK (1) | HK1210951A1 (enExample) |
| IL (1) | IL199674A (enExample) |
| MX (1) | MX2009007045A (enExample) |
| RU (1) | RU2462262C2 (enExample) |
| WO (1) | WO2008084368A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009098533A1 (en) * | 2008-02-08 | 2009-08-13 | Debiopharm Sa | Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| WO2011098805A1 (en) | 2010-02-09 | 2011-08-18 | Biotica Technology Limited | Sanglifehrin based compounds |
| WO2011098808A1 (en) | 2010-02-09 | 2011-08-18 | Biotica Technology Limited | Sanglifehrin based compounds |
| BR112012019866A8 (pt) | 2010-02-09 | 2017-12-26 | Biotica Tech Limited | Composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto |
| GB201008123D0 (en) | 2010-05-17 | 2010-06-30 | Biotica Tech Ltd | Novel compounds |
| KR101935213B1 (ko) | 2010-12-20 | 2019-01-03 | 뉴로바이브 파마슈티컬 에이비 | 상글리페린 유도체 및 이의 제조 방법 |
| JO3063B1 (ar) | 2011-03-29 | 2017-03-15 | Neurovive Pharmaceutical Ab | مركب مبتكر وطرق لانتاجه |
| CA2872162A1 (en) | 2012-05-07 | 2013-11-14 | Novartis Ag | Pharmacokinetic modulation with alisporivir |
| AR090964A1 (es) | 2012-05-09 | 2014-12-17 | Novartis Ag | Proceso para la elaboracion de undecapeptidos ciclicos |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0296122B1 (en) * | 1987-06-17 | 1993-09-29 | Sandoz Ag | Cyclosporins and their use as pharmaceuticals |
| KR0148748B1 (ko) | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
| CA2329709A1 (en) * | 1998-04-24 | 1999-11-04 | Mitokor | Compounds and methods for treating mitochondria-associated diseases |
| USRE40987E1 (en) * | 1998-07-01 | 2009-11-17 | Debiopharm S.A. | Cyclosporin with improved activity profile |
| US6323039B1 (en) * | 1999-06-22 | 2001-11-27 | Mitokor | Compositions and methods for assaying subcellular conditions and processes using energy transfer |
| US7368423B1 (en) | 2001-12-05 | 2008-05-06 | The Scripps Research Institute | Composition and method for treating chronic allograft rejection |
| GB0320638D0 (en) * | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
| WO2009098533A1 (en) * | 2008-02-08 | 2009-08-13 | Debiopharm Sa | Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy |
-
2008
- 2008-01-03 RU RU2009129212/15A patent/RU2462262C2/ru not_active IP Right Cessation
- 2008-01-03 BR BRPI0806265-0A patent/BRPI0806265A2/pt not_active Application Discontinuation
- 2008-01-03 CN CN201510378165.7A patent/CN105056207A/zh active Pending
- 2008-01-03 JP JP2009544475A patent/JP5801534B2/ja not_active Expired - Fee Related
- 2008-01-03 US US12/522,118 patent/US8450281B2/en not_active Expired - Fee Related
- 2008-01-03 EP EP08702176A patent/EP2124992A2/en not_active Withdrawn
- 2008-01-03 CA CA2674296A patent/CA2674296C/en not_active Expired - Fee Related
- 2008-01-03 MX MX2009007045A patent/MX2009007045A/es active IP Right Grant
- 2008-01-03 WO PCT/IB2008/000003 patent/WO2008084368A2/en not_active Ceased
- 2008-01-03 AU AU2008204344A patent/AU2008204344B2/en not_active Ceased
- 2008-01-03 CN CN200880001665A patent/CN101616683A/zh active Pending
-
2009
- 2009-07-02 IL IL199674A patent/IL199674A/en active IP Right Grant
-
2010
- 2010-05-20 HK HK15111764.4A patent/HK1210951A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008084368A8 (en) | 2009-09-17 |
| US20100041593A1 (en) | 2010-02-18 |
| RU2462262C2 (ru) | 2012-09-27 |
| CA2674296C (en) | 2015-11-24 |
| JP5801534B2 (ja) | 2015-10-28 |
| IL199674A (en) | 2016-10-31 |
| WO2008084368A2 (en) | 2008-07-17 |
| BRPI0806265A2 (pt) | 2011-09-06 |
| AU2008204344A1 (en) | 2008-07-17 |
| RU2009129212A (ru) | 2011-02-10 |
| AU2008204344A9 (en) | 2012-06-28 |
| AU2008204344B2 (en) | 2013-01-31 |
| US8450281B2 (en) | 2013-05-28 |
| WO2008084368A9 (en) | 2009-02-26 |
| HK1210951A1 (en) | 2016-05-13 |
| JP2010514834A (ja) | 2010-05-06 |
| CN105056207A (zh) | 2015-11-18 |
| EP2124992A2 (en) | 2009-12-02 |
| CN101616683A (zh) | 2009-12-30 |
| CA2674296A1 (en) | 2008-07-17 |
| IL199674A0 (en) | 2010-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009007045A (es) | Ciclosporina no inmunosupresora para el tratamiento de distrofia muscular congenita de ullrich. | |
| MX2010006025A (es) | Analogo de pterina para tratar afeccion sensible a bh4. | |
| MX2009009428A (es) | Analogos de ciclopamina heterociclicos y metodos de uso de los mismos. | |
| PH12013501215A1 (en) | Glucagon analogs exhibiting gip receptor activity | |
| GEP20156329B (en) | CHEMICAL MODIFICATIONS OF miRNA INHIBITORS AND MIMETICS | |
| PH12013500870A1 (en) | Heterocyclic compounds and uses thereof | |
| MX2009009153A (es) | Pirano-pirazol-aminas. | |
| EP2595482A4 (en) | ALDOSTERONSYNTHASEHEMMER | |
| WO2012078902A3 (en) | Proteostasis regulators | |
| SG178999A1 (en) | Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | |
| PL2627346T3 (pl) | Przechodzące przez komórkę peptydowe inhibitory szlaku przekazywania sygnałów przez JNK do zastosowania w leczeniu zapalenia błony naczyniowej oka | |
| PH12012502129A1 (en) | New combination therapy in treatment of oncological and fibrotic diseases | |
| MX2009009154A (es) | Derivados de espiro-pirano-pirazol. | |
| MY150600A (en) | Use of opioid antagonists for treating urinary retention | |
| TN2012000581A1 (en) | Piperidinyl compound as a modulator of chemokine receptor activity | |
| MY151104A (en) | Novel use | |
| MX2010007669A (es) | Metodos para inhibir la angiogenesis utilizando antagonistas de egfl8. | |
| TN2010000342A1 (en) | Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy | |
| MX2010004814A (es) | Metodos para tratar esclerodermia. | |
| EP3345596A3 (en) | Inhibitors of beta-hydrolase for treatment of cancer | |
| MX2012015112A (es) | Uso de antagonistas del receptor de adenosina a2b para el tratamiento de la hipertension pulmonar. | |
| WO2011091410A8 (en) | Trpv4 antagonists | |
| PE20130603A1 (es) | Composicion farmaceutica que contiene un inhibidor de esteroide c17,20 liasa | |
| WO2009108635A3 (en) | Novel compositions for treatment of diseases related to activated lymphocytes | |
| HK1184969A (en) | Methods of use cyclic amide derivatives to treat sigma receptor-mediated disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |